INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $126,000 | -29.6% | 25,200 | +0.8% | 0.00% | – |
Q3 2021 | $179,000 | -61.4% | 25,000 | -50.0% | 0.00% | – |
Q2 2021 | $464,000 | +2.2% | 50,000 | +196.6% | 0.00% | -100.0% |
Q2 2020 | $454,000 | +790.2% | 16,858 | +36.5% | 0.00% | – |
Q4 2017 | $51,000 | – | 12,348 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
Keystone Financial Group | 109,897 | $42,751 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |